7Baggers
 Castle Biosciences’ Founder, President and CEO Derek  GlobeNewswire Wed, 01 Oct 2025 20:32:20 GMT
 immunovia secures control over pancreasure test supply chain  Biostock Tue, 23 Sep 2025 11:13:18 GMT
 castle biosciences (nasdaq:cstl) insider sells $29,417.83 in stock  MarketBeat Tue, 23 Sep 2025 09:09:13 GMT
 SciBase receives initial order from Castle Biosciences  Biostock Tue, 23 Sep 2025 08:53:32 GMT
 castle biosciences (nasdaq:cstl) insider sells $29,417.83 in stock  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 castle biosciences (nasdaq:cstl) insider sells $29,417.83 in stock  MarketBeat Sat, 20 Sep 2025 22:13:16 GMT
 Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025  markets.businessinsider.com Thu, 18 Sep 2025 08:43:27 GMT
 rebecca critchley-thorne, phd's profile page  Technology Networks Wed, 17 Sep 2025 00:18:28 GMT
 ai-enabled spatial proteomics improves prediction of progression to cancer  Technology Networks Tue, 16 Sep 2025 11:14:06 GMT
 AI-Enabled Spatial Proteomics Improves Cancer Prediction  Technology Networks Tue, 16 Sep 2025 11:09:15 GMT
 immunovia enters into collaboration with inova schar cancer  Biostock Mon, 15 Sep 2025 07:00:00 GMT
 Castle Biosciences at Baird Conference: Strategic Growth Insights  Investing.com Wed, 10 Sep 2025 17:35:25 GMT
 canaccord genuity keeps their buy rating on castle biosciences (cstl)  The Globe and Mail Wed, 10 Sep 2025 11:27:00 GMT
 new data at american foregut society's 2025 annual meeting  GlobeNewswire Wed, 10 Sep 2025 08:08:30 GMT
 Castle Biosciences Shows Improved Relative Price Performance; Still Shy Of Benchmark  Investor's Business Daily Wed, 10 Sep 2025 07:00:00 GMT
 castle biosciences announces new data on tissuecypher test  TipRanks Tue, 09 Sep 2025 11:41:31 GMT
 braidwell lp buys new stake in castle biosciences, inc. $cstl  MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
 Castle Biosciences Sees IBD RS Rating Improve To 77  Investor's Business Daily Tue, 02 Sep 2025 07:00:00 GMT
 castle biosciences executive makes significant stock sale  TipRanks Sat, 30 Aug 2025 02:19:09 GMT
 Castle Biosciences Executive Makes Significant Stock Sale  TipRanks Fri, 29 Aug 2025 07:00:00 GMT
 published on: 2025-08-28 14:00:18  Newser Thu, 28 Aug 2025 19:00:18 GMT

Castle Biosciences, Inc
(NASDAQ:CSTL) 

CSTL stock logo

Castle Biosciences, Inc., a commercial-stage dermatological cancer company, focuses to provide diagnostic and prognostic solutions for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify high-risk patients with stage I and II melano...

Founded: 2007
IPO Price: $16 (Jul 25, 2019)
Full Time Employees: 133
CEO: Derek J. Maetzold  
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends